Seed Newsvine
These biotech stocks are getting hammered by shocking brittle-bone
treatment study results
-
Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs
after disappointing trial results for setrusumab.
14 minutes ago
No comments:
Post a Comment